Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) vs. 3M (NYSE:MMM) Head to Head Contrast

3M (NYSE:MMM) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both multi-sector conglomerates companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, valuation and analyst recommendations.

Institutional and Insider Ownership

65.3% of 3M shares are owned by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. 0.3% of 3M shares are owned by company insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Volatility and Risk

3M has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500.

Earnings and Valuation

This table compares 3M and Health Sciences Acquisitions Co. 2″s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
3M	$32.64 billion	2.18	-$7.00 billion	$7.92	16.46
Health Sciences Acquisitions Co. 2	N/A	N/A	-$380,000.00	N/A	N/A

Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than 3M.

Profitability

This table compares 3M and Health Sciences Acquisitions Co. 2’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
3M	15.37%	104.66%	10.18%
Health Sciences Acquisitions Co. 2	N/A	N/A	-2.38%

Analyst Ratings

This is a breakdown of recent ratings for 3M and Health Sciences Acquisitions Co. 2, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
3M	2	3	11	0	2.56
Health Sciences Acquisitions Co. 2	0	0	0	0	0.00

3M presently has a consensus price target of $144.87, indicating a potential upside of 11.13%. Given 3M’s stronger consensus rating and higher probable upside, research analysts plainly believe 3M is more favorable than Health Sciences Acquisitions Co. 2.

Summary

3M beats Health Sciences Acquisitions Co. 2 on 8 of the 11 factors compared between the two stocks.

About 3M

3M Company provides diversified technology services in the United States and internationally. The company’s Safety and Industrial segment offers industrial abrasives and finishing for metalworking applications; autobody repair solutions; closure systems for personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles. Its Transportation and Electronics segment provides ceramic solutions; attachment/bonding products, films, sound, and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage; light management films and electronics assembly solutions; packaging and interconnection solutions; semiconductor production materials; data centers solutions; and reflective signage for highway, and vehicle safety. The company’s Consumer segment provides consumer bandages, braces, supports, and consumer respirators; home cleaning products; retail abrasives, paint accessories, car care DIY products, picture hanging, and consumer air quality solutions; and stationery products. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers. 3M Company was founded in 1902 and is headquartered in Saint Paul, Minnesota.

About Health Sciences Acquisitions Co. 2

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.